Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic

Based on mucosal immunization to promote both mucosal and systemic immune responses, next-generation coronavirus disease 2019 (COVID-19) vaccines would be administered intranasally or orally. The goal of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is to provide adequate imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Miteva, Dimitrina, Peshevska-Sekulovska, Monika, Snegarova, Violeta, Batselova, Hristiana, Alexandrova, Radostina, Velikova, Tsvetelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523321/
https://www.ncbi.nlm.nih.gov/pubmed/36188733
http://dx.doi.org/10.5501/wjv.v11.i5.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523321/
https://www.ncbi.nlm.nih.gov/pubmed/36188733
http://dx.doi.org/10.5501/wjv.v11.i5.221

Ejemplares similares